Global Generic Active Pharmaceutical Ingredients Market Research Report 2021
- Published Date : 23-06-2021
- Pages : 107
- Report Id : 35041
- Categories : Healthcare
This report studies the global Generic Active Pharmaceutical Ingredients market status and forecast, categorizes the global Generic Active Pharmaceutical Ingredients market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
In 2020, the global Generic Active Pharmaceutical Ingredients market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx.x % between 2021 and 2027.
The major manufacturers covered in this report
Pfizer, Inc. (U.S.)
Novartis International AG (Switzerland)
Sanofi (France)
Boehringer Ingelheim (Germany)
Bristol-Myers Squibb (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (U.S.)
GlaxoSmithKline plc (U.K.)
Merck & Co., Inc. (U.S.)
AbbVie Inc. (U.S.)
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The regional scope of the study is as follows:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Monoclonal Antibodies
Hormones
Cytokines
Fusion Proteins
Therapeutic Enzymes
Vaccines
Blood Factors
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Oncology
Diabetes
Cardiovascular Disease
CNS and Neurological Disorders
Endocrinology
Others
The study objectives of this report are:
To analyze and study the global Generic Active Pharmaceutical Ingredients sales, value, status (2016-2020) and forecast (2021-2027).
Focuses on the key Generic Active Pharmaceutical Ingredients manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Generic Active Pharmaceutical Ingredients are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Generic Active Pharmaceutical Ingredients Manufacturers
Generic Active Pharmaceutical Ingredients Distributors/Traders/Wholesalers
Generic Active Pharmaceutical Ingredients Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Generic Active Pharmaceutical Ingredients market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents
Global Generic Active Pharmaceutical Ingredients Market Research Report 2021
1 Generic Active Pharmaceutical Ingredients Market Overview
1.1 Product Overview and Scope of Generic Active Pharmaceutical Ingredients
1.2 Generic Active Pharmaceutical Ingredients Segment by Type (Product Category)
1.2.1 Global Generic Active Pharmaceutical Ingredients Production and CAGR (%) Comparison by Type (Product Category)( 2016-2027)
1.2.2 Global Generic Active Pharmaceutical Ingredients Production Market Share by Type (Product Category) in 2020
1.2.3 Monoclonal Antibodies
1.2.4 Hormones
1.2.5 Cytokines
1.2.6 Fusion Proteins
1.2.7 Therapeutic Enzymes
1.2.8 Vaccines
1.2.9 Blood Factors
1.3 Global Generic Active Pharmaceutical Ingredients Segment by Application
1.3.1 Generic Active Pharmaceutical Ingredients Consumption (Sales) Comparison by Application ( 2016-2027)
1.3.2 Oncology
1.3.3 Diabetes
1.3.4 Cardiovascular Disease
1.3.5 CNS and Neurological Disorders
1.3.6 Endocrinology
1.3.7 Others
1.4 Global Generic Active Pharmaceutical Ingredients Market by Region ( 2016-2027)
1.4.1 Global Generic Active Pharmaceutical Ingredients Market Size (Value) and CAGR (%) Comparison by Region ( 2016-2027)
1.4.2 North America Status and Prospect ( 2016-2027)
1.4.3 Europe Status and Prospect ( 2016-2027)
1.4.4 Asia-Pacific Status and Prospect ( 2016-2027)
1.4.5 South America Status and Prospect ( 2016-2027)
1.4.6 Middle East & Africa Status and Prospect ( 2016-2027)
1.5 Global Market Size (Value) of Generic Active Pharmaceutical Ingredients ( 2016-2027)
1.5.1 Global Generic Active Pharmaceutical Ingredients Revenue Status and Outlook ( 2016-2027)
1.5.2 Global Generic Active Pharmaceutical Ingredients Capacity, Production Status and Outlook ( 2016-2027)
2 Global Generic Active Pharmaceutical Ingredients Market Competition by Manufacturers
2.1 Global Generic Active Pharmaceutical Ingredients Capacity, Production and Share by Manufacturers ( 2016-2021)
2.1.1 Global Generic Active Pharmaceutical Ingredients Capacity and Share by Manufacturers ( 2016-2021)
2.1.2 Global Generic Active Pharmaceutical Ingredients Production and Share by Manufacturers ( 2016-2021)
2.2 Global Generic Active Pharmaceutical Ingredients Revenue and Share by Manufacturers ( 2016-2021)
2.3 Global Generic Active Pharmaceutical Ingredients Average Price by Manufacturers ( 2016-2021)
2.4 Manufacturers Generic Active Pharmaceutical Ingredients Manufacturing Base Distribution, Sales Area and Product Type
2.5 Generic Active Pharmaceutical Ingredients Market Competitive Situation and Trends
2.5.1 Generic Active Pharmaceutical Ingredients Market Concentration Rate
2.5.2 Generic Active Pharmaceutical Ingredients Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Generic Active Pharmaceutical Ingredients Capacity, Production, Revenue (Value) by Region ( 2016-2021)
3.1 Global Generic Active Pharmaceutical Ingredients Capacity and Market Share by Region ( 2016-2021)
3.2 Global Generic Active Pharmaceutical Ingredients Production and Market Share by Region ( 2016-2021)
3.3 Global Generic Active Pharmaceutical Ingredients Revenue (Value) and Market Share by Region ( 2016-2021)
3.4 Global Generic Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin ( 2016-2021)
3.5 North America Generic Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin ( 2016-2021)
3.6 Europe Generic Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin ( 2016-2021)
3.7 Asia-Pacific Generic Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin ( 2016-2021)
3.8 South America Generic Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin ( 2016-2021)
3.9 Middle East & Africa Generic Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin ( 2016-2021)
4 Global Generic Active Pharmaceutical Ingredients Supply (Production), Consumption, Export, Import by Region ( 2016-2021)
4.1 Global Generic Active Pharmaceutical Ingredients Consumption by Region ( 2016-2021)
4.2 North America Generic Active Pharmaceutical Ingredients Production, Consumption, Export, Import ( 2016-2021)
4.3 Europe Generic Active Pharmaceutical Ingredients Production, Consumption, Export, Import ( 2016-2021)
4.4 Asia-Pacific Generic Active Pharmaceutical Ingredients Production, Consumption, Export, Import ( 2016-2021)
4.5 South America Generic Active Pharmaceutical Ingredients Production, Consumption, Export, Import ( 2016-2021)
4.6 Middle East & Africa Generic Active Pharmaceutical Ingredients Production, Consumption, Export, Import ( 2016-2021)
5 Global Generic Active Pharmaceutical Ingredients Production, Revenue (Value), Price Trend by Type
5.1 Global Generic Active Pharmaceutical Ingredients Production and Market Share by Type ( 2016-2021)
5.2 Global Generic Active Pharmaceutical Ingredients Revenue and Market Share by Type ( 2016-2021)
5.3 Global Generic Active Pharmaceutical Ingredients Price by Type ( 2016-2021)
5.4 Global Generic Active Pharmaceutical Ingredients Production Growth by Type ( 2016-2021)
6 Global Generic Active Pharmaceutical Ingredients Market Analysis by Application
6.1 Global Generic Active Pharmaceutical Ingredients Consumption and Market Share by Application ( 2016-2021)
6.2 Global Generic Active Pharmaceutical Ingredients Consumption Growth Rate by Application ( 2016-2021)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Generic Active Pharmaceutical Ingredients Manufacturers Profiles/Analysis
7.1 Pfizer, Inc. (U.S.)
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin ( 2016-2021)
7.1.4 Main Business/Business Overview
7.2 Novartis International AG (Switzerland)
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin ( 2016-2021)
7.2.4 Main Business/Business Overview
7.3 Sanofi (France)
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Sanofi (France) Generic Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin ( 2016-2021)
7.3.4 Main Business/Business Overview
7.4 Boehringer Ingelheim (Germany)
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin ( 2016-2021)
7.4.4 Main Business/Business Overview
7.5 Bristol-Myers Squibb (U.S.)
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin ( 2016-2021)
7.5.4 Main Business/Business Overview
7.6 Teva Pharmaceutical Industries Ltd. (Israel)
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin ( 2016-2021)
7.6.4 Main Business/Business Overview
7.7 Eli Lilly and Company (U.S.)
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin ( 2016-2021)
7.7.4 Main Business/Business Overview
7.8 GlaxoSmithKline plc (U.K.)
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin ( 2016-2021)
7.8.4 Main Business/Business Overview
7.9 Merck & Co., Inc. (U.S.)
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin ( 2016-2021)
7.9.4 Main Business/Business Overview
7.10 AbbVie Inc. (U.S.)
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Capacity, Production, Revenue, Price and Gross Margin ( 2016-2021)
7.10.4 Main Business/Business Overview
8 Generic Active Pharmaceutical Ingredients Manufacturing Cost Analysis
8.1 Generic Active Pharmaceutical Ingredients Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Generic Active Pharmaceutical Ingredients
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Generic Active Pharmaceutical Ingredients Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Generic Active Pharmaceutical Ingredients Major Manufacturers in 2020
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Generic Active Pharmaceutical Ingredients Market Forecast ( 2021-2027)
12.1 Global Generic Active Pharmaceutical Ingredients Capacity, Production, Revenue Forecast ( 2021-2027)
12.1.1 Global Generic Active Pharmaceutical Ingredients Capacity, Production and Growth Rate Forecast ( 2021-2027)
12.1.2 Global Generic Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast ( 2021-2027)
12.1.3 Global Generic Active Pharmaceutical Ingredients Price and Trend Forecast ( 2021-2027)
12.2 Global Generic Active Pharmaceutical Ingredients Production, Consumption , Import and Export Forecast by Region ( 2021-2027)
12.2.1 North America Generic Active Pharmaceutical Ingredients Production, Revenue, Consumption, Export and Import Forecast ( 2021-2027)
12.2.2 Europe Generic Active Pharmaceutical Ingredients Production, Revenue, Consumption, Export and Import Forecast ( 2021-2027)
12.2.3 Asia-Pacific Generic Active Pharmaceutical Ingredients Production, Revenue, Consumption, Export and Import Forecast ( 2021-2027)
12.2.4 South America Generic Active Pharmaceutical Ingredients Production, Revenue, Consumption, Export and Import Forecast ( 2021-2027)
12.2.5 Middle East & Africa Generic Active Pharmaceutical Ingredients Production, Revenue, Consumption, Export and Import Forecast ( 2021-2027)
12.3 Global Generic Active Pharmaceutical Ingredients Production, Revenue and Price Forecast by Type ( 2021-2027)
12.4 Global Generic Active Pharmaceutical Ingredients Consumption Forecast by Application ( 2021-2027)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Generic Active Pharmaceutical Ingredients
Figure Global Generic Active Pharmaceutical Ingredients Production (K MT) and CAGR (%) Comparison by Types (Product Category) ( 2016-2027)
Figure Global Generic Active Pharmaceutical Ingredients Production Market Share by Types (Product Category) in 2020
Figure Product Picture of Monoclonal Antibodies
Table Major Manufacturers of Monoclonal Antibodies
Figure Product Picture of Hormones
Table Major Manufacturers of Hormones
Figure Product Picture of Cytokines
Table Major Manufacturers of Cytokines
Figure Product Picture of Fusion Proteins
Table Major Manufacturers of Fusion Proteins
Figure Product Picture of Therapeutic Enzymes
Table Major Manufacturers of Therapeutic Enzymes
Figure Product Picture of Vaccines
Table Major Manufacturers of Vaccines
Figure Product Picture of Blood Factors
Table Major Manufacturers of Blood Factors
Figure Global Generic Active Pharmaceutical Ingredients Consumption (K MT) by Applications ( 2016-2027)
Figure Global Generic Active Pharmaceutical Ingredients Consumption Market Share by Applications in 2020
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Cardiovascular Disease Examples
Table Key Downstream Customer in Cardiovascular Disease
Figure CNS and Neurological Disorders Examples
Table Key Downstream Customer in CNS and Neurological Disorders
Figure Endocrinology Examples
Table Key Downstream Customer in Endocrinology
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Generic Active Pharmaceutical Ingredients Market Size (Million USD), Comparison (K MT) and CAGR (%) by Regions ( 2016-2027)
Figure North America Generic Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate ( 2016-2027)
Figure Europe Generic Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate ( 2016-2027)
Figure Asia-Pacific Generic Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate ( 2016-2027)
Figure South America Generic Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate ( 2016-2027)
Figure Middle East & Africa Generic Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate ( 2016-2027)
Figure Global Generic Active Pharmaceutical Ingredients Revenue (Million USD) Status and Outlook ( 2016-2027)
Figure Global Generic Active Pharmaceutical Ingredients Capacity, Production (K MT) Status and Outlook ( 2016-2027)
Figure Global Generic Active Pharmaceutical Ingredients Major Players Product Capacity (K MT) ( 2016-2021)
Table Global Generic Active Pharmaceutical Ingredients Capacity (K MT) of Key Manufacturers ( 2016-2021)
Table Global Generic Active Pharmaceutical Ingredients Capacity Market Share of Key Manufacturers ( 2016-2021)
Figure Global Generic Active Pharmaceutical Ingredients Capacity (K MT) of Key Manufacturers in 2020
Figure Global Generic Active Pharmaceutical Ingredients Capacity (K MT) of Key Manufacturers in 2021
Figure Global Generic Active Pharmaceutical Ingredients Major Players Product Production (K MT) ( 2016-2021)
Table Global Generic Active Pharmaceutical Ingredients Production (K MT) of Key Manufacturers ( 2016-2021)
Table Global Generic Active Pharmaceutical Ingredients Production Share by Manufacturers ( 2016-2021)
Figure 2020 Generic Active Pharmaceutical Ingredients Production Share by Manufacturers
Figure 2020 Generic Active Pharmaceutical Ingredients Production Share by Manufacturers
Figure Global Generic Active Pharmaceutical Ingredients Major Players Product Revenue (Million USD) ( 2016-2021)
Table Global Generic Active Pharmaceutical Ingredients Revenue (Million USD) by Manufacturers ( 2016-2021)
Table Global Generic Active Pharmaceutical Ingredients Revenue Share by Manufacturers ( 2016-2021)
Table 2020 Global Generic Active Pharmaceutical Ingredients Revenue Share by Manufacturers
Table 2021 Global Generic Active Pharmaceutical Ingredients Revenue Share by Manufacturers
Table Global Market Generic Active Pharmaceutical Ingredients Average Price (USD/MT) of Key Manufacturers ( 2016-2021)
Figure Global Market Generic Active Pharmaceutical Ingredients Average Price (USD/MT) of Key Manufacturers in 2020
Table Manufacturers Generic Active Pharmaceutical Ingredients Manufacturing Base Distribution and Sales Area
Table Manufacturers Generic Active Pharmaceutical Ingredients Product Category
Figure Generic Active Pharmaceutical Ingredients Market Share of Top 3 Manufacturers
Figure Generic Active Pharmaceutical Ingredients Market Share of Top 5 Manufacturers
Table Global Generic Active Pharmaceutical Ingredients Capacity (K MT) by Region ( 2016-2021)
Figure Global Generic Active Pharmaceutical Ingredients Capacity Market Share by Region ( 2016-2021)
Figure Global Generic Active Pharmaceutical Ingredients Capacity Market Share by Region ( 2016-2021)
Figure 2020 Global Generic Active Pharmaceutical Ingredients Capacity Market Share by Region
Table Global Generic Active Pharmaceutical Ingredients Production by Region ( 2016-2021)
Figure Global Generic Active Pharmaceutical Ingredients Production (K MT) by Region ( 2016-2021)
Figure Global Generic Active Pharmaceutical Ingredients Production Market Share by Region ( 2016-2021)
Figure 2020 Global Generic Active Pharmaceutical Ingredients Production Market Share by Regio
Direct Purchase
Your perfect start with Research AlliedWant to customize this report?
This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Avail PDF Sample Reports
You may also be lnterested in..
Research Allied ™ Copyright © 2025 .